This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Back to overview

René Medema group

ReneMedema.jpg

René Medema

Director of Research, Group Leader, professor

Personal details

Experience

René Medema became director of the NKI in 2012, and brought an established research group to the institute. He has extensive experience studying the mechanisms underlying cell division, particularly the molecular checkpoints that control progression of the cell cycle. Many classic anti-cancer drugs kill cells by targeting the cell cycle, for example by damaging DNA or by perturbing assembly of the mitotic spindle, which is required for cell division. René's group aims to gain a clearer understanding of the cellular responses to these drugs in order to better predict drug responses and experimentally test new and potentially more effective anti-cancer strategies.

Share this page